Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Prasugrel

Prasugrel Reactions 1704, p313 - 2 Jun 2018 Puncture-site bleeding: 2 case reports In a postmarketing observational study of 732 patients (UMIN000014699), two patients were described [ages and sexes not stated], of whom one patient developed femoral- radial puncture-site bleeding and one patient developed brachial puncture-site bleeding during treatment with oral prasugrel tablets for acute coronary syndrome [dosages, times to reactions onsets and outcomes not stated]. Author comment: "Each patient started prasugrel treatment ≥1 month before the end of the study period". "The incidence of ADRs was 8.6% . . .Regarding puncture site bleeding, the puncture site locations were . . . femoral + radial (one patient), and brachial (one patient)." Nakamura M, et al. Prasugrel for Japanese patients with acute coronary syndrome in short-term clinical practice (PRASFIT-Practice I): a postmarketing observational study. Cardiovascular Intervention and Therapeutics 33: 135-145, No. 2, Apr 2018. Available from: URL: http://doi.org/10.1007/s12928-017-0459-8 - Japan 803322739 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704 http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Reactions Weekly Springer Journals

Prasugrel

Reactions Weekly , Volume 1704 (1) – Jun 2, 2018
Download PDF
1 page

Prasugrel

Abstract

Reactions 1704, p313 - 2 Jun 2018 Puncture-site bleeding: 2 case reports In a postmarketing observational study of 732 patients (UMIN000014699), two patients were described [ages and sexes not stated], of whom one patient developed femoral- radial puncture-site bleeding and one patient developed brachial puncture-site bleeding during treatment with oral prasugrel tablets for acute coronary syndrome [dosages, times to reactions onsets and outcomes not stated]. Author comment: "Each...
Loading next page...
 
/lp/springer_journal/prasugrel-f4le3M51rZ

References (1)

Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer International Publishing AG, part of Springer Nature
Subject
Medicine & Public Health; Drug Safety and Pharmacovigilance; Pharmacology/Toxicology
ISSN
0114-9954
eISSN
1179-2051
DOI
10.1007/s40278-018-46956-1
Publisher site
See Article on Publisher Site

Abstract

Reactions 1704, p313 - 2 Jun 2018 Puncture-site bleeding: 2 case reports In a postmarketing observational study of 732 patients (UMIN000014699), two patients were described [ages and sexes not stated], of whom one patient developed femoral- radial puncture-site bleeding and one patient developed brachial puncture-site bleeding during treatment with oral prasugrel tablets for acute coronary syndrome [dosages, times to reactions onsets and outcomes not stated]. Author comment: "Each patient started prasugrel treatment ≥1 month before the end of the study period". "The incidence of ADRs was 8.6% . . .Regarding puncture site bleeding, the puncture site locations were . . . femoral + radial (one patient), and brachial (one patient)." Nakamura M, et al. Prasugrel for Japanese patients with acute coronary syndrome in short-term clinical practice (PRASFIT-Practice I): a postmarketing observational study. Cardiovascular Intervention and Therapeutics 33: 135-145, No. 2, Apr 2018. Available from: URL: http://doi.org/10.1007/s12928-017-0459-8 - Japan 803322739 0114-9954/18/1704-0001/$14.95 Adis © 2018 Springer International Publishing AG. All rights reserved Reactions 2 Jun 2018 No. 1704

Journal

Reactions Weekly – Springer Journals

Published: Jun 2, 2018

There are no references for this article.